Literature DB >> 9573089

Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle.

I Gentschev1, I Glaser, W Goebel, D J McKeever, A Musoke, V T Heussler.   

Abstract

The p67 sporozoite antigen of Theileria parva has been fused to the C-terminal secretion signal of Escherichia coli hemolysin and expressed in secreted form by attenuated Salmonella dublin aroA strain SL5631. The recombinant p67 antigen was detected in the supernatant of transformed bacterial cultures. Immunization trials in cattle revealed that SL5631 secreting the antigen provoked a 10-fold-higher antibody response to p67 than recombinant SL5631 expressing but not secreting p67. Immunized calves were challenged with a 80% lethal dose of T. parva sporozoites and monitored for the development of infection. Two of three calves immunized intramuscularly with the p67-secreting SL5631 strain were found to be protected, whereas only one of three animals immunized with the nonsecreting p67-expressing SL5631 strain was protected. This is the first demonstration that complete eukaryotic antigens fused to the C-terminal portion of E. coli hemolysin can be exported from attenuated Salmonella strains and that such exported antigens can protect cattle against subsequent parasite challenge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573089      PMCID: PMC108163          DOI: 10.1128/IAI.66.5.2060-2064.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  TolC, an Escherichia coli outer membrane protein required for hemolysin secretion.

Authors:  C Wandersman; P Delepelaire
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Bovine cytotoxic T-cell clones specific for cells infected with the protozoan parasite Theileria parva: parasite strain specificity and class I major histocompatibility complex restriction.

Authors:  B M Goddeeris; W I Morrison; A J Teale; A Bensaid; C L Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Transport of hemolysin across the outer membrane of Escherichia coli requires two functions.

Authors:  W Wagner; M Vogel; W Goebel
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

4.  Genetically restricted cell-mediated cytotoxicity in cattle immune to Theileria parva.

Authors:  E M Eugui; D L Emery
Journal:  Nature       Date:  1981-03-19       Impact factor: 49.962

5.  Dose dependent responses of cattle to Theileria parva stabilate.

Authors:  T T Dolan; A S Young; G J Losos; I McMilian; C E Minder; K Soulsby
Journal:  Int J Parasitol       Date:  1984-02       Impact factor: 3.981

6.  Identification of a Theileria mutans-specific antigen for use in an antibody and antigen detection ELISA.

Authors:  J M Katende; B M Goddeeris; S P Morzaria; C G Nkonge; A J Musoke
Journal:  Parasite Immunol       Date:  1990-07       Impact factor: 2.280

7.  Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains.

Authors:  R A Strugnell; D Maskell; N Fairweather; D Pickard; A Cockayne; C Penn; G Dougan
Journal:  Gene       Date:  1990-03-30       Impact factor: 3.688

8.  Salmonella strain secreting active listeriolysin changes its intracellular localization.

Authors:  I Gentschev; Z Sokolovic; H J Mollenkopf; J Hess; S H Kaufmann; M Kuhn; G F Krohne; W Goebel
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Evidence for a common protective antigenic determinant on sporozoites of several Theileria parva strains.

Authors:  A J Musoke; V M Nantulya; F R Rurangirwa; G Buscher
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

10.  Release of a chimeric protein into the medium from Escherichia coli using the C-terminal secretion signal of haemolysin.

Authors:  N Mackman; K Baker; L Gray; R Haigh; J M Nicaud; I B Holland
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

View more
  8 in total

Review 1.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  A vaccine candidate for post-weaning diarrhea in swine constructed with a live attenuated Salmonella delivering Escherichia coli K88ab, K88ac, FedA, and FedF fimbrial antigens and its immune responses in a murine model.

Authors:  Jin Hur; Barry D Stein; John Hwa Lee
Journal:  Can J Vet Res       Date:  2012-07       Impact factor: 1.310

3.  Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine.

Authors:  Ho Young Kang; Jay Srinivasan; Roy Curtiss
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Partially assembled K99 fimbriae are required for protection.

Authors:  Miguel A Ascón; Javier Ochoa-Repáraz; Nancy Walters; David W Pascual
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Authors:  Wei Xin; Soo-Young Wanda; Yuhua Li; Shifeng Wang; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

6.  Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.

Authors:  O G Gómez-Duarte; M F Pasetti; A Santiago; M B Sztein; S L Hoffman; M M Levine
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.

Authors:  Helen S Garmory; Richard W Titball; Kate F Griffin; Ulrike Hahn; Reinhard Böhm; Wolfgang Beyer
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study.

Authors:  Anne-Francoise Petavy; Carlos Hormaeche; Samia Lahmar; Hammou Ouhelli; Alejandro Chabalgoity; Thierry Marchal; Samira Azzouz; Fernanda Schreiber; Gabriela Alvite; Marie-Elisabeth Sarciron; Duncan Maskell; Adriana Esteves; Georges Bosquet
Journal:  PLoS Negl Trop Dis       Date:  2008-01-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.